Hangzhou Tigermed Consulting

China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

AdvertisementChina’s private sectorBusinessChina Business China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS Company’s shares jump in Hong…